Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Dexmedetomidine by BioXcel Therapeutics for Alcohol Dependence: Likelihood of Approval
Dexmedetomidine is under clinical development by BioXcel Therapeutics and currently in Phase I for Alcohol Dependence. According to GlobalData, Phase...
Dexmedetomidine by BioXcel Therapeutics for Post-Traumatic Stress Disorder (PTSD): Likelihood of Approval
Dexmedetomidine is under clinical development by BioXcel Therapeutics and currently in Phase I for Post-Traumatic Stress Disorder (PTSD). According to...
Dexmedetomidine by BioXcel Therapeutics for Alzheimer's Disease: Likelihood of Approval
Dexmedetomidine is under clinical development by BioXcel Therapeutics and currently in Phase III for Alzheimer's Disease. According to GlobalData, Phase...
Dexmedetomidine by BioXcel Therapeutics for Bipolar Disorder (Manic Depression): Likelihood of Approval
Dexmedetomidine is under clinical development by BioXcel Therapeutics and currently in Phase I for Bipolar Disorder (Manic Depression). According to...
Dexmedetomidine by IX Biopharma for Anxiety Disorders: Likelihood of Approval
Dexmedetomidine is under clinical development by IX Biopharma and currently in Phase I for Anxiety Disorders. According to GlobalData, Phase...